Nikolas Plevris, BMedSci, MBCHB, MRCP, GI Specialist Registrar, The Edinburgh IBD Unit, Western General Hospital, Edinburgh, discusses monitoring and targets in IBD. Future disease monitoring will include point-of-care testing, telehealth consultations, mobile-based applications and wearables, artificial intelligence for endoscopy and as a decision-making support tool, and the potential inclusion of diet, gut microbiome, and molecular parameters. Future monitoring strategies should empower patients, be less invasive and more cost-effective, and help improve clinical outcomes.